Jihyun An

4.4k total citations · 1 hit paper
102 papers, 2.9k citations indexed

About

Jihyun An is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jihyun An has authored 102 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Epidemiology, 54 papers in Hepatology and 13 papers in Molecular Biology. Recurrent topics in Jihyun An's work include Liver Disease Diagnosis and Treatment (45 papers), Hepatocellular Carcinoma Treatment and Prognosis (30 papers) and Hepatitis B Virus Studies (25 papers). Jihyun An is often cited by papers focused on Liver Disease Diagnosis and Treatment (45 papers), Hepatocellular Carcinoma Treatment and Prognosis (30 papers) and Hepatitis B Virus Studies (25 papers). Jihyun An collaborates with scholars based in South Korea, China and United States. Jihyun An's co-authors include Young‐Suk Lim, Han Chu Lee, Ju Hyun Shim, Kang Mo Kim, Yung Sang Lee, So Jung Lee, Danbi Lee, Gi‐Ae Kim, Seungbong Han and So Yeon Kim and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jihyun An

91 papers receiving 2.9k citations

Hit Papers

Efficacy and Safety of Transarterial Chemoembolization Pl... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihyun An South Korea 29 1.9k 1.8k 421 336 315 102 2.9k
Catherine Frenette United States 25 1.2k 0.6× 917 0.5× 389 0.9× 202 0.6× 185 0.6× 87 1.8k
Po‐Hong Liu United States 26 1.4k 0.7× 1.1k 0.6× 681 1.6× 187 0.6× 403 1.3× 97 2.5k
Elena Campello Italy 32 597 0.3× 708 0.4× 430 1.0× 536 1.6× 165 0.5× 152 3.1k
Isaburo Fujimoto Japan 22 1.2k 0.6× 1.2k 0.7× 349 0.8× 224 0.7× 204 0.6× 46 2.4k
Olivier Guillaud France 26 1.2k 0.6× 1.3k 0.7× 614 1.5× 62 0.2× 45 0.1× 100 2.3k
Bernhard Scheiner Austria 29 1.8k 0.9× 1.6k 0.9× 580 1.4× 210 0.6× 142 0.5× 147 2.5k
Chun‐Ju Chiang Taiwan 23 303 0.2× 570 0.3× 391 0.9× 305 0.9× 314 1.0× 103 2.4k
Joana Ferrer Spain 23 2.7k 1.4× 1.4k 0.8× 1.6k 3.8× 290 0.9× 479 1.5× 134 4.2k
Janice H. Jou United States 17 1.3k 0.7× 1.4k 0.8× 319 0.8× 174 0.5× 139 0.4× 43 2.1k
Myung‐Whun Sung South Korea 18 407 0.2× 1.0k 0.6× 489 1.2× 221 0.7× 103 0.3× 40 1.9k

Countries citing papers authored by Jihyun An

Since Specialization
Citations

This map shows the geographic impact of Jihyun An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihyun An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihyun An more than expected).

Fields of papers citing papers by Jihyun An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihyun An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihyun An. The network helps show where Jihyun An may publish in the future.

Co-authorship network of co-authors of Jihyun An

This figure shows the co-authorship network connecting the top 25 collaborators of Jihyun An. A scholar is included among the top collaborators of Jihyun An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihyun An. Jihyun An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Kim, Gunho, et al.. (2025). Second-line antidiabetic drugs: friend or foe of the liver. PubMed. 25(2). 187–203. 1 indexed citations
4.
An, Jihyun, Ha Il Kim, In Hye Song, et al.. (2025). LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C. Radiology. 314(3). e241856–e241856.
5.
Choi, G. J., et al.. (2024). CURE: Context- and Uncertainty-Aware Mental Disorder Detection. 17924–17940. 2 indexed citations
6.
An, Jihyun, Young Eun Chon, Mi Na Kim, et al.. (2024). Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis. Clinical and Molecular Hepatology. 30(Suppl). S134–S146. 3 indexed citations
7.
Jin, Young‐Joo, Hee Yeon Kim, Young Ju Suh, et al.. (2024). Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis. Clinical and Molecular Hepatology. 30(Suppl). S159–S171. 4 indexed citations
8.
Han, Ji Won, Hee Yeon Kim, Mi Na Kim, et al.. (2024). Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis. Clinical and Molecular Hepatology. 30(Suppl). S147–S158. 5 indexed citations
10.
An, Jihyun & Joo Hyun Sohn. (2022). Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials. Clinical and Molecular Hepatology. 29(Suppl). S268–S275. 21 indexed citations
11.
Guo, Moning, Jihyun An, Peng Chiong Tan, et al.. (2022). Acute effect of air pollutants’ peak-hour concentrations on ischemic stroke hospital admissions among hypertension patients in Beijing, China, from 2014 to 2018. Environmental Science and Pollution Research. 29(27). 41617–41627. 5 indexed citations
12.
An, Jihyun, Deokhoon Kim, Ji‐Hyun Song, et al.. (2021). Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas. Hepatology. 75(4). 997–1011. 17 indexed citations
13.
Tian, Xue, Yingting Zuo, Shuohua Chen, et al.. (2020). Association of changes in lipids with risk of myocardial infarction among people without lipid-lowering therapy. Atherosclerosis. 301. 69–78. 4 indexed citations
14.
Lee, Young‐Sun, Jae Geun Lee, Jihyun An, et al.. (2020). A Survey of Liver Cancer Specialists’ Views on the National Liver Cancer Screening Program in Korea. PubMed. 20(1). 53–59. 7 indexed citations
15.
Feng, Wei, Haibin Li, Shuo Wang, et al.. (2018). Short-term PM10 and emergency department admissions for selective cardiovascular and respiratory diseases in Beijing, China. The Science of The Total Environment. 657. 213–221. 86 indexed citations
16.
An, Jihyun, Ju Hyun Shim, Seungbong Han, et al.. (2018). Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study. PLoS ONE. 13(3). e0193232–e0193232. 45 indexed citations
17.
Kim, Gwang‐Un, Sang Young Han, Hyun‐Jung Kim, Jihyun An, & Young‐Suk Lim. (2017). Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response. Journal of Viral Hepatitis. 24(11). 990–997. 9 indexed citations
18.
Kim, Hyung‐Don, Jihyun An, Jin Hyoung Kim, et al.. (2016). Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 27(4). 504–513. 3 indexed citations
19.
An, Jihyun, Young‐Suk Lim, Gi‐Ae Kim, et al.. (2014). Tenofovir Monotherapy in Chronic Hepatitis B Patients with Genotypic Resistance to Previous Antiviral Therapy. 46–46. 1 indexed citations
20.
Kim, Gi‐Ae, Young‐Suk Lim, Jihyun An, et al.. (2014). HBSAG Seroclearance after Nucleoside Analogue Therapy in Patients with Chronic Hepatitis B. 43–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026